Introduction
Cerebral aneurysm (CA) affects 4-5% of the general population in the United States, and CA rupture leads to devastating clinical consequences. 1 Although the pathogenesis of CA is not fully understood, a growing body of evidences suggest that CA is closely associated with chronic inflammation at the arterial bifurcation in which arterial walls are subjected to excessive hemodynamic stress. 2, 3 We reported that monocyte chemoattractant protein-1 (MCP-1) had a role in CA formation by recruiting monocytes or macrophages into CA walls, 4 which secret proteinases such as matrix metalloproteinase (MMP)-2, -9 and cystein cathepsins, causing degenerative changes in CA walls. 5, 6 Vascular smooth muscle cells (VSMCs) in CA walls also express MMPs, cathepsins and MCP-1, [4] [5] [6] suggesting a substantial role of VSMCs in CA development. However, their regulatory mechanisms remain to be elucidated.
Several transcription factors have been shown to mediate vascular inflammatory responses in VSMCs. In this study, we focused on Ets-1, a member of the Ets transcription factor family. Ets family is defined by a highly conserved DNA-binding domain (Ets domain) containing a winged helix-turn-helix structure. Although originally described as proto-oncogenes, Ets family members have been shown to regulate a wide variety of biological processes, including cellular growth and differentiation. 7 Ets-1 is a prototypical member of this family and is expressed in VSMCs. 7 To obtain insight into the role of Ets-1 in CA development, we have examined the expression of Ets-1 and its downstream genes in experimentally induced rat CAs. And an inhibitory effect of DNA binding of Ets-1 on CA development has been investigated by using ets decoy oligodeoxynucleotides (ODNs).
Results

Ets-1 expression and activation in rat CA walls
Immunohistochemistry showed Ets-1 expression especially in the media of CA walls at 1 month after CA induction (Figure 1e ), whereas Ets-1 was scarcely expressed in control cerebral arterial walls (Figure 1d ). Ets-1 was principally expressed in the CA wall, although a small amount of Ets-1 expression was detected in the adjacent arterial wall (Supplementary Figure 2) . Ets-1 expression was reduced from 1 to 3 months of CA induction (Figure 1f) . In western blotting, Ets-1 expression was significantly upregulated 1 month after CA induction (Po0.01, n ¼ 5) and Ets-1 expression was reduced from 1 to 3 months of CA induction (P ¼ 0.018, n ¼ 5) (Figure 1g and h) . In enzyme-linked mobility shift assay (EMSA), one major band could be detected at 1 month after CA induction (Figure 1i ). This band was completely abolished by competition with oligonucleotides containing a consensus sequence for the ets family transcription factors, but not with a mutated binding motif, confirming the band was specific for the ets family. Incubation with the anti-Ets-1 antibody resulted in a supershift of the ets complex band.
Double immunohistostaining demonstrated that Ets-1 was mainly expressed in VSMCs (smooth muscle a-actin (SMA) 66.3±13.7%, CD31 14.0±6.0%, CD68 19.7±9.5%, n ¼ 5 in each group, SMA vs CD31 Po0.01, SMA vs CD68 Po0.01) (Figure 2 ).
Ets-1 binding to MCP-1 promoter
In double immunohistochemistry, expression of Ets-1 and MCP-1 was well merged in the media of CA walls (Figure 3b ). Both MCP-1 promoter and MMP-9 promoter have a consensus binding sequence (5 0 -ggaa-3 0 ) for ets Ets-1 promotes cerebral aneurysm progression T Aoki et al family transcription factors (Figure 3c ). In chromatin immunoprecipitation (CHIP) assays, MCP-1 promoter sequence was immunoprecipitated with the anti-Ets-1 polyclonal antibody and was detected after PCR at 1 month after CA induction (Figure 3d ). The band for the ets-binding site at À832 bp was more prominent at 1 month after CA induction than at 3 months after CA induction. On the other hand, the binding for the etsbinding site at À102 bp in the MCP-1 promoter further increased at 3 months ( Figure 3d ). No band could be detected after PCR using primers for ets-binding sites on the MMP-9 promoter. Without immunoprecipitation, equal size of bands for both MCP-1 promoter and MMP-9 promoter were detected in all lanes, confirming that the same amount of DNA was used in each experiment ( Figure 3d ).
Effect of ets decoy ODN on rat CA formation 
Effect of ets decoy ODN on MCP-1 expression and macrophage infiltration in rat CA walls
In a quantitative real-time PCR analysis, MCP-1 expression was upregulated at 1 month after aneurysm induction in the scrambled decoy ODN-treated group, whereas the upregulated expression of MCP-1 was significantly inhibited by the ets decoy ODN treatment (sham operation vs scrambled decoy P ¼ 0.042; scrambled decoy vs ets decoy P ¼ 0.028; n ¼ 6 in each group) ( Figure 5a ). In immunohistochemistry, MCP-1 expression was upregulated in rat CA walls at 1 month after CA induction in the scrambled decoy ODN-treated group (Figure 5f ). By the ets decoy ODN treatment, the upregulated expression of MCP-1 was inhibited especially in the media (Figure 5g ). In contrast, MCP-1 expression in endothelial cells was preserved after the ets decoy ODN treatment. Macrophage infiltration into CA walls was significantly inhibited by the ets decoy ODN treatment (scrambled decoy 7.1 ± 2.0 cells per 100 mm 
Discussion
Ample evidence supports the notion that chronic inflammation has a fundamental role in CA development. 2, 3, 8 Human histological studies demonstrated the accumulation of inflammatory cells, especially macrophages, in CA walls. 3, 9, 10 In this study, we have identified Ets-1 transcription factor as another important inflammatory mediator involved in CA development. Ets-1 is Ets-1 promotes cerebral aneurysm progression T Aoki et al mainly activated in VSMCs in the media (Figures 1 and 6 ).
In the past few years, several studies revealed a novel role of Ets-1 in the regulation of vascular inflammation and remodeling in various vascular diseases. Est-1 regulates the expression of vascular endothelial growth factor and hepatocyte growth factor, thereby regulating angiogenesis. 11 Ets-1 was highly expressed in VSMCs derived from human atherosclerotic plaques 12 and in VSMCs in the rat carotid artery after balloon injury. 13, 14 Ets-1-deficient mice showed a marked reduction in vascular remodeling in response to systemic administration of angiotensin II. 15 Transactivation of Ets-1 induces the expression of platelet-derived growth factor, thus promoting VSMC proliferation. 16 Upregulated expression and activation of Ets-1 in VSMCs in CA walls strongly suggest the contribution of Ets-1 to vascular inflammation and remodeling occurring in CA walls.
This study also identified MCP-1 as a downstream gene of Ets-1 during CA development. Various proinflammatory genes are involved in CA formation, such as MMP-2, MMP-9, iNOS, IL-1b, MCP-1 and VCAM-1.
4,5,17
Among them, MMP-9 and MCP-1 have a consensus binding sequence against Ets-1 in their promoter regions. Zhan et al. 15 demonstrated that Ets-1 is a critical regulator for angiotensin II-mediated MCP-1 expression in VSMCs. CHIP assays revealed that Ets-1 bound to the promoter region of MCP-1, but not to that of MMP-9 ( Figure 3) . The time course of CHIP assay for the À832 bp site was coincided with that of immunohistochemistry and western blotting, although the binding for the À102 bp site further increased at 3 months. These results suggest that the À832 bp site predominantly may regulate Ets-1-mediated MCP-1 expression or that binding to both the À832 bp site and the À102 bp site may be required for it. Coexpression of Ets-1 and MCP-1 in CA walls supports the notion that MCP-1 is a major downstream target of Ets-1 in the process of CA development. Furthermore, ets decoy ODNs markedly inhibited MCP-1 expression in the media (Figure 5a ). MCP-1 is abundantly expressed also in endothelial cells especially at the early phase of CA formation, and MCP-1 expression in endothelial cells is regulated by nuclear factor-k B (NF-kB). 4 The ets decoy ODN treatment did not abolish MCP-1 expression in endothelial cells, suggesting a different role between NF-kB and Ets-1 in transcriptional regulation of MCP-1 in CA walls.
Ets decoy ODN treatment resulted in the suppression of CA enlargement without affecting systemic blood Ets-1 promotes cerebral aneurysm progression T Aoki et al pressure. One major mechanism for it is the inhibition of macrophage recruitment by downregulating MCP-1 expression in VSMCs. Although a direct interaction between Ets-1 and MMP-9 could not be demonstrated, decreased macrophage accumulation leads to decreased secretion of MMP-2 and -9 from macrophages in CA walls. Strictly speaking, the role of Ets-1 in CA development cannot be correctly assessed by this study, because ets decoy ODN inhibited the transactivation through all ets family transcriptional factors including Ets-2. In fact, the ets complex band was not completely abolished in the supershift assay, suggesting that another ets family transcription factor may be involved in CA formation and progression. Gene expression profile study using DNA microarrays showed that more than 200 proinflammatory gene expressions were involved in CA development. 17, 18 Using experimentally induced CA models, we have also identified several important factors promoting CA development including MMP-2 and -9, 5 cathepthins, 6 MCP-1 4 and p47 phox. 19 Although the inhibition of each promoting factor resulted in the prevention of CA enlargement, the inhibitory effect was not sufficient for providing a complete cessation of CA progression. As a key transcription factor regulates multiple proinflammatory genes, inhibition of the key transcription factor may be a promising therapeutic strategy We previously reported that CA induction was effectively blocked by the treatment with NF-kB decoy ODNs ,if it was administered at the early stage of CA development. 2 However, the NF-kB inhibition by decoy ODNs could not prevent the progression of preexisting CAs. Therefore, we concluded that NF-kB had a pivotal role in the early stage of CA formation. Results of this study indicate that Ets-1 is principally activated in VSMCs in CA walls, implicating a synergistic effect of NF-kB decoy ODN and ets decoy ODN. In abdominal aortic aneurysm (AAA), treatment with chimeric decoy ODNs containing both NF-kB and ets-binding sites significantly decreased the size of AAA. 20 The effect of chimeric decoy ODNs on CA will be examined in the next study.
Recent studies revealed that nonself nucleotides provoke an innate immune response. 21 Therefore, the effect of ets decoy ODN on CA formation should be carefully assessed. Ets decoy ODN contains CpG motif, which is recognized by toll-like receptor 9 (TLR9), and could cause a proinflammatory response. 22 However, TLR9 mRNA was not detected in real-time PCR in rat cerebral arteries, 23 suggesting that innate immunity mediated by TLR9 has little influence on the inhibitory effect of ets decoy ODNs on CA progression. DNAdependent activator of the interferon regulator factor (DAI) is also a DNA sensor and an activator of the innate immune response. 24 DAI recognizes cytosolic long DNA fragment with a length 4100 bp. 25 Therefore, decoy ODN is likely to escape from the DNA-sensing mechanism mediated by DAI.
Another obstacle to overcome for applying decoy ODNs in a clinical setting is an administration method. In this study, we injected ets decoy ODNs intrathecally, because ODNs are unstable and degraded by nuclease in the blood. Further modification and encapsulation of ODNs are required for a more practical and effective mode of administration for clinical application. After resolving such problems, we will be able to treat human CAs much less invasively, which can be treated only by surgical clipping or endovascular coiling at present.
Materials and methods
Induction of experimental CAs in rats
Animal care and experiments complied with the Japanese community standards on the care and use of laboratory animals.
CAs were induced as previously described by Nagata et al. 26 Under general anesthesia, the left common carotid artery and posterior branches of the bilateral renal arteries were ligated with 10-0 nylon in 7-week-old male Sprague-Dawley rats (Oriental Bioservice, Osaka, Japan). Animals were with fed food containing 8% sodium chloride and 0.12% b-aminopropionitrile (Tokyo Chemical, Tokyo, Japan), a LOX inhibitor that catalyzed the crosslinking of collagen and elastin. Blood pressure was measured by tail-cuff method without any anesthesia.
Immunohistochemistry
At 1 or 3 months after CA induction, all rats were deeply anesthetized and perfused transcardially with 4% paraformaldehyde. As a control, sham-operated male Sprague-Dawley rats were killed as described above. The anterior cerebral artery/olfactory artery (ACA/OA) bifurcation was subjected to fluorescence immunohistochemstry as previously described. 5 The primary antibodies used in this study are listed below: rabbit polyclonal anti-Ets-1 antibody (Santa-Cruz Biotechnology, Santa Cruz, CA, USA), mouse monoclonal anti-SMA antibody (Labvision, Fermont, CA, USA), goat monoclonal anti-CD31 antibody (Santa-Cruz Biotechnology), rabbit polyclonal anti-CD68 antibody (HyCult, Uden, the Netherlands) and goat polyclonal anti-MCP-1 antibody (Santa-Cruz Biotechnology).
The number of SMA, CD68 or CD31/Ets-1 doublepositive cells was counted in the serial section (n ¼ 5). The 4 0 , 6-diamino-2-phenylindole (DAPI) staining was simultaneously carried out to identify each cell. The ratio of the number of double-positive cells to that of total Ets-1-positive cells was calculated.
Western blotting
At 1 or 3 months after aneurysm induction, the ACA/ OA bifurcation was homogenized and dissolved in Laemmli sample buffer (Bio-Rad, Hercules, CA, USA). In total, 15 mg of protein per samples was used. After electrophoresis, transfer and blocking with 5% ECL blocking agent (GE Healthcare, Buckinghamshire, UK), membranes (Hybond-P, GE Healthcare) were incubated with primary antibodies followed by incubation with horseradish peroxidase-conjugated secondary antibodies (GE Healthcare). Signals were detected by ECL Plus Western Blotting Detection Reagents (GE Healthcare). Densitometric analyses included five independent experiments.
Quantitative real-time PCR
Before or 1 month after aneurysm induction, rats were killed as described above. Total RNA from the whole circle of Willis was isolated, converted into cDNA and subjected to quantitative (real-time) PCR using RNeasy Fibrous Tissue Mini Kit, Sensiscript reverse transcriptase, 0 -aagcaatgctgtcaccttccc-3 0 for b-actin. For quantification, the second-derivative maximum method was used for cross-point determination, using LightCycler Software 3.3 (Roche Diagnostics). Six independent samples were examined in one experiment.
EMSA
Nuclear protein extracts from a whole circle of Willis was subjected to EMSA using biotin 3 0 end-labeled oligonucleotides containing c-Ets-binding consensus sequence (5 0 -GGAA-3 0 ), as previously described. 2 To confirm the specificity, a 200-fold excess amount of nonlabeled oligonucleotides (cold probe) or mutated biding motif (5 0 -GGCC-3 0 ) was added. A supershift assay was carried out as previously described using an anti-Ets-1 antibody (Santa-Cruz Biotechnology). 2 
CHIP
CHIP was carried out using EpiQuik Tissue Chromatin Immunoprecipitation Kit (Epigentek, Brooklyn, NY, USA) according to the manufacturer's instructions. Briefly, a whole circle of Willis with or without CA induction was dissected and crosslinked by formaldehyde. After homogenization, cell lysis, sonication and immunoprecipitation were carried out using the anti-Ets-1 antibody (Santa Cruz Biotechnology). As a negative control study, normal mouse IgG was used. After protein digestion by proteinase K, DNA fragment was purified by ethanol precipitation. PCR was carried out using primers determined by the promoter sequence of rat MCP-1 and -9.
Decoy ODNs treatment
Ets and scrambled decoy ODNs were synthesized as previously described. 28 The sequence of ets decoy ODNs was 5 0 -aattcaccggaagtattcga-3 0 and 5 0 -tcgaatacttccggtga atc-3 0 . Scrambled decoy ODN (5 0 -ttgccgtacctgacttagcc-3 0 and 5 0 -ggctaagtcaggtacggcaa-3 0 ) served as a control. In all, 40 mg of ets or scrambled decoy ODN dissolved in 60 ml phosphate-buffered saline was injected into the cisterna magna every 2 weeks under general anesthesia, according to a previous study. 2 Distribution of injected decoy ODN in cerebral arterial walls was confirmed using fluorescein isothiocyanate-conjugated decoy ODN (Supplementary Figure 1) . Decoy ODN injection was started at the same time as CA induction. After 1 month, the ACA/OA bifurcation was stripped and observed under a light microscope after Elastica van Gieson (EvG) staining. Aneurysm size was calculated as the mean of the maximal longitudinal diameter and the maximal transverse diameter by NIH Image (National Institutes of Health, Bethesda, MD, USA). Macrophage accumulation was assessed by the number of CD68-positive cells in a 100 mm 2 area.
Immunohistochemistry for human samples
Human CA samples were obtained from seven patients who underwent neck clipping for unruptured CAs with informed consent. As a control, we used the middle cerebral artery (n ¼ 4) obtained at autopsy. Samples were fixed in formaldehyde solution and embedded in paraffin. After deparaffinization and blocking, 4 mm sections were incubated with a rabbit polyclonal anti-Ets-1 antibody (Santa-Cruz Biotechnology) for 1 h followed by incubation with a fluorescein isothiocyanateconjugated secondary antibody for 1 h at room temperature. Then, the slides were observed under a fluorescence microscope. For double staining, slides were incubated with a mouse monoclonal anti-SMA antibody (Labvision) or a goat polyclonal anti-MCP-1 antibody (Santa-Cruz Biotechnology) for 30 min, followed by the incubation with a Cy3-conjugated secondary antibody at room temperature.
Statistical analysis
Data (mean ± s.d.) were analyzed by the Mann-Whitney U-test for a two-group comparison, and Kruskal-Wallis one-way analysis of variance on ranks followed by the Turkey-Kramer test for a multiple comparison. Po0.05 was considered statistically significant.
